Tevogen Bio Holdings Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Tevogen Bio Holdings Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-7.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 56% of Healthcare companies in United States.
Cash Cushion Ratio
−16%Debt, after subtracting cash, equals 16% of its market value (net debt).
Lower than 82% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Tevogen Bio Holdings Inc. made a loss over the last year. Tevogen Bio Holdings Inc. owes $2.88 for every $1 it owns. Tevogen Bio Holdings Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTevogen Bio Holdings Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-4.99Tevogen Bio Holdings Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$44 MThe total market value of all of Tevogen Bio Holdings Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeTevogen Bio Holdings Inc.'s net worth is negative ($9 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
2.88×Tevogen Bio Holdings Inc. owes $2.88 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Dividend yield
NoneTevogen Bio Holdings Inc. does not currently pay a dividend.
Profit growth
LossTevogen Bio Holdings Inc. made a loss in each of the last two years.
Interest cover
Not coveredTevogen Bio Holdings Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTevogen Bio Holdings Inc. had $7 M more debt than cash (net debt) at Dec 2025.
Questions
How much does Tevogen Bio Holdings Inc. owe compared with what it owns?
Tevogen Bio Holdings Inc. owes $2.88 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Does Tevogen Bio Holdings Inc. pay a dividend?
No. Tevogen Bio Holdings Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.